Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials - Concepedia

Concepedia

Publication | Open Access

Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials

DOI Full Paper Access

27

Citations

28

References

2020

Year

Florence Lerebours, Marina Pulido, Emmanuelle Fourme, Marc Debled, Véronique Becette, Hervé Bonnefoi, Sofía Rivera, Gaëtan MacGrogan, Marie‐Ange Mouret‐Reynier, C. Tunon de Lara,

British Journal of Cancer

References

	Year	Citations

Page 1